Collaboration Arrangements - Additional Information (Detail) (Merck KGaA, USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | 35 Months Ended | ||
---|---|---|---|---|---|
Mar. 31, 2014
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2014
|
|
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
Upfront and milestone payments received to date | $ 12.5us-gaap_ProceedsFromCollaborators | $ 110.0us-gaap_ProceedsFromCollaborators | $ 110.0us-gaap_ProceedsFromCollaborators | ||
Merck KGaA's percentage share of worldwide development expenses | 70.00%thld_WorldwideDevelopmentExpensesSharePercentage | ||||
Collaboration payments achieved and received | 42.5thld_CollaborationPayments | 67.5thld_CollaborationPayments | |||
Revenue recognized by the Company | 14.7us-gaap_DeferredRevenueRevenueRecognized | 12.5us-gaap_DeferredRevenueRevenueRecognized | 5.9us-gaap_DeferredRevenueRevenueRecognized | ||
Company earned a reimbursement for eligible worldwide development expenses | 21.9us-gaap_RecoveryOfDirectCosts | 16.5us-gaap_RecoveryOfDirectCosts | 13.1us-gaap_RecoveryOfDirectCosts | ||
United States
|
|||||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
Portion of profits that Company is eligible to participate, depending upon total sales |
50.00%thld_PortionOfProfitsDependingOnSales / dei_LegalEntityAxis = thld_MerckKGaAMember / us-gaap_StatementGeographicalAxis = country_US |
||||
Regulatory and Development Milestones | Maximum
|
|||||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
Potential future milestones |
100thld_PotentialMilestonePayments / dei_LegalEntityAxis = thld_MerckKGaAMember / us-gaap_RangeAxis = us-gaap_MaximumMember / thld_RequirementOfEligibleFutureMilestonePaymentsAxis = thld_RegulatoryAndDevelopmentMilestonesMember |
||||
Commercialization Milestones | Maximum
|
|||||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
Potential future milestones |
$ 340thld_PotentialMilestonePayments / dei_LegalEntityAxis = thld_MerckKGaAMember / us-gaap_RangeAxis = us-gaap_MaximumMember / thld_RequirementOfEligibleFutureMilestonePaymentsAxis = thld_CommercializationMilestonesMember |
X | ||||||||||
- Definition
Collaboration payments achieved and received. No definition available.
|
X | ||||||||||
- Definition
Portion of profits depending on sales. No definition available.
|
X | ||||||||||
- Definition
Potential milestone payments. No definition available.
|
X | ||||||||||
- Definition
Worldwide development expenses share percentage. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Cash received from collaborators during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|